Access Bio, Inc. (KOSDAQ:950130)

Access Bio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	203,656	182,552	302,841	414,360	569,632	784,363
Market Cap Growth	-35.85%	-39.72%	-26.91%	-27.26%	-27.38%	1061.10%
Enterprise Value	-171,303	-114,354	-43,387	-123,881	568,975	809,032
Last Close Price	5790.00	5190.00	8970.00	12200.00	14944.24	20595.03
PE Ratio	-	-	-	1.20	3.00	16.25
Forward PE	-	22.67	22.67	22.67	22.67	22.67
PS Ratio	2.06	1.62	0.87	0.40	1.13	6.44
PB Ratio	0.32	0.28	0.52	0.66	1.96	9.05
P/TBV Ratio	0.32	0.28	0.52	0.67	1.99	9.44
P/FCF Ratio	-	10.23	-	1.18	4.40	31.06
P/OCF Ratio	-	9.17	-	1.12	3.48	22.01
EV/Sales Ratio	-	-	-	-	1.13	6.64
EV/EBITDA Ratio	-	-	-	-	2.14	11.57
EV/EBIT Ratio	-	-	-	-	2.19	12.16
EV/FCF Ratio	7.75	-	-	-	4.40	32.03
Debt / Equity Ratio	0.10	0.10	0.13	0.12	0.24	0.55
Debt / EBITDA Ratio	-	8.83	1.93	0.16	0.26	0.68
Debt / FCF Ratio	-	3.70	-	0.22	0.54	1.87
Asset Turnover	0.14	0.16	0.44	1.56	1.65	1.01
Inventory Turnover	2.43	2.13	2.44	2.54	2.65	1.73
Quick Ratio	15.33	11.49	8.38	3.01	1.85	1.13
Current Ratio	16.45	12.38	9.51	3.65	2.37	1.61
Return on Equity (ROE)	-1.67%	-0.17%	-0.87%	76.35%	100.91%	83.46%
Return on Assets (ROA)	-1.97%	-1.10%	1.74%	44.09%	53.02%	34.67%
Return on Capital (ROIC)	-2.02%	-1.14%	2.01%	55.13%	65.70%	41.59%
Return on Capital Employed (ROCE)	-	-	3.40%	67.90%	85.50%	66.20%
Earnings Yield	-4.73%	-0.19%	-1.05%	83.66%	33.30%	6.15%
FCF Yield	-10.85%	9.78%	-40.45%	84.58%	22.72%	3.22%
Buyback Yield / Dilution	-2.25%	-1.38%	10.73%	-1.46%	-7.75%	-21.66%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.